The U.S. Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer advocates worried about youth use.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗